Albumin-Bound Paclitaxel: all 674 studies that test it
Page 6 of 7. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) VaccineWithdrawnNCT03554109Phase 2
- Scheduling Nab-paclitaxel With GemcitabineCompletedNCT03529175Phase 2
- NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaTerminatedNCT03524898Phase 1/2
- Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung CancerTerminatedNCT03520686Phase 3
- Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid TumorsCompletedNCT03507491Phase 1
- An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast CancerCompletedNCT03505528Phase 1
- Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial CarcinomaCompletedNCT03464734Phase 2
- Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic CancerCompletedNCT03415802Phase 2
- Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerCompletedNCT03412799Phase 1
- The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic CancerStatus unknownNCT03401827Phase 4
- Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC AdenocarcinomaWithdrawnNCT03361319Phase 1/2
- Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)CompletedNCT03345810Phase 2
- Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic CancerCompletedNCT03316599Phase 1
- Stromal TARgeting for PAncreatic Cancer (STAR_PAC)CompletedNCT03307148Phase 1
- Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBCCompletedNCT03289819Phase 2
- Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer PatientsStatus unknownNCT03278015Phase 2
- Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing SarcomaCompletedNCT03275818Phase 2
- Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung CancerStatus unknownNCT03262948Phase 3
- Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLCStatus unknownNCT03219762Phase 2
- QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03197571Phase 1/2
- QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based ChemotherapyWithdrawnNCT03175666Phase 1/2
- QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHLWithdrawnNCT03169790Phase 1/2
- QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRCWithdrawnNCT03169777Phase 1/2
- QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03169764Phase 1/2
- QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 InhibitorsWithdrawnNCT03169738Phase 1/2
- QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03167177Phase 1/2
- QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 TherapyWithdrawnNCT03167164Phase 1/2
- PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast CancerCompletedNCT03166085Phase 1
- Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary CancersCompletedNCT03162510Phase 1
- Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial TractCompletedNCT03051373Phase 2
- Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT02921022Not applicable
- Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer PatientsCompletedNCT02812992Phase 4
- EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly With advanCed breasT CancerCompletedNCT02783222Phase 2
- Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal CancerStatus unknownNCT02762474Phase 1/2
- Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung CancerCompletedNCT02733250Phase 1/2
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder CancerWithdrawnNCT02718742Phase 2
- Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic CancerStatus unknownNCT02717091Phase 2
- Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)TerminatedNCT02707328Phase 1
- Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer PatientsCompletedNCT02707159Phase 2
- Abraxane in Patients With Visceral Metastases Dominant Metastatic Breast CancerCompletedNCT02687490Phase 2
- Denosumab as an add-on Neoadjuvant Treatment (GeparX)CompletedNCT02682693Phase 2
- ACY-1215 + Nab-paclitaxel in Metastatic Breast CancerCompletedNCT02632071Phase 1
- Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic CancerCompletedNCT02620800Phase 1
- Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast CancerTerminatedNCT02598310Phase 2
- Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic CarcinomaCompletedNCT02588443Phase 1
- TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid TumorsCompletedNCT02574663Phase 1
- QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-PaclitaxelCompletedNCT02559674Phase 1
- Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic CancerCompletedNCT02550327Early Phase 1
- Evaluation of Safety and Efficacy of Electrochemotherapy in the Treatment of Pancreatic AdenocarcinomaCompletedNCT02514421Phase 1
- ARQ-761 Treatment With Gemcitabine/Nab-Paclitaxel Chemotherapy In Pancreatic CancerTerminatedNCT02514031Phase 1
- Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative ResectionStatus unknownNCT02506842Phase 3
- NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric AdenocarcinomaStatus unknownNCT02486601Phase 2
- A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic CancerCompletedNCT02481635Phase 1/2
- Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.WithdrawnNCT02405910Phase 2
- A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic CancerCompletedNCT02399137Phase 2
- Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT02394535Phase 1
- Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic AdenocarcinomaCompletedNCT02391662Phase 2
- Nab-paclitaxel in Combination With Gemcitabine in Fragile Patients With Advanced Pancreatic CancerCompletedNCT02382263Phase 1/2
- Phase I/II Study of LDE225 With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerCompletedNCT02358161Phase 1/2
- Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic CancerActive, not recruitingNCT02340117Phase 2
- Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by SurgeryActive, not recruitingNCT02336087Phase 1
- Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT02333188Phase 1
- Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung CarcinomaTerminatedNCT02319889Early Phase 1
- A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid TumorsTerminatedNCT02317419Phase 1
- Study of Trametinib and Nab-paclitaxel in Patients With MelanomaWithdrawnNCT02300935Phase 1
- Nab-Paclitaxel Plus Gemcitabine With Concurrent MR-Guided IMRT in Patients With Locally Advanced Pancreatic CancerCompletedNCT02283372Phase 1
- The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)CompletedNCT02273713Phase 1/2
- A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic CancerCompletedNCT02272738Phase 1
- Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT02270814Phase 2
- Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic HyperbilirubinemiaTerminatedNCT02267707Phase 1
- The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung CancerStatus unknownNCT02262897Phase 2
- Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric CancerCompletedNCT02251951Phase 2
- Study of Gemcitabine and Abraxane for Pancreas CancerTerminatedNCT02242409Phase 2
- Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric CancerCompletedNCT02229058Phase 2
- Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric CancerStatus unknownNCT02229045Phase 2
- A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasStatus unknownNCT02215447Phase 2
- A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic CancerActive, not recruitingNCT02207465Phase 1
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast CancerTerminatedNCT02183805Phase 2
- Biological Effect of Nab-paclitaxel Combined to Gemcitabine in Metastatic Pancreatic CancerCompletedNCT02174887Phase 1
- Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic CancerCompletedNCT02138383Phase 1
- Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic CancerStatus unknownNCT02135822Phase 2
- Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)TerminatedNCT02124369Phase 2
- Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic CancerStatus unknownNCT02124317Phase 2
- Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian CancerWithdrawnNCT02117817Phase 1
- Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic CancerCompletedNCT02109341Phase 1/2
- T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast CancerCompletedNCT02073916Phase 1
- Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain MetastasesWithdrawnNCT02065466Phase 1/2
- Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic CancerCompletedNCT02050178Phase 1
- Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic CancerWithdrawnNCT02048943Phase 1
- Phase I Dose Escalation Study of Intravenous VCN-01 With or Without Gemcitabine and Abraxane® in Patients With Advanced Solid TumorsCompletedNCT02045602Phase 1
- A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic CancerCompletedNCT02045589Phase 1
- Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer.CompletedNCT02043730Phase 2
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of EsophagusWithdrawnNCT02033538Phase 2
- Nab-paclitaxel Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02023021Phase 2
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung CancerStatus unknownNCT02016209Phase 2
- A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic CancerCompletedNCT02005315Phase 1
- First Line Chemotherapy for Advanced CancerTerminatedNCT01980810Phase 2
- Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)Status unknownNCT01971281Phase 1/2
- Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung CancerStatus unknownNCT01969955Phase 2